References
- Herselman M, Esau N, Kruger JM, et al. Relationship between body mass index and mortality in adults on maintenance hemodialysis: a systematic review. J Ren Nutr. 2010;20:281–292.
- Kalantar-Zadeh K, Abbott KC, Salahudeen AK, et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005;81:543–554.
- Bosello O, Donataccio MP, Cuzzolaro M. Obesity or obesities? Controversies on the association between body mass index and premature mortality. Eat Weight Disord. 2016;21:165–174.
- Pinho EM, Lourenço P, Silva S, et al. Higher BMI in heart failure patients is associated with longer survival only in the absence of diabetes. J Cardiovasc Med (Hagerstown). 2015;16:576–582.
- Mafra D, Guebre-Egziabher F, Fouque D. Body mass index, muscle and fat in chronic kidney disease: questions about survival. Nephrol Dial Transplant. 2008;23:2461–2466.
- Kakiya R, Shoji T, Tsujimoto Y, et al. Body fat mass and lean mass as predictors of survival in hemodialysis patients. Kidney Int. 2006;70:549–556.
- Caetano C, Valente A, Oliveira T, et al. Body composition and mortality predictors in hemodialysis patients. J Ren Nutr. 2016;26:81–86.
- Mak RH, Cheung W, Cone RD, et al. Leptin and inflammation-associated cachexia in chronic kidney disease. Kidney Int. 2006;69:794–797.
- Marcelli D, Brand K, Ponce P, et al. Longitudinal changes in body composition in patients after initiation of hemodialysis therapy: results from an international cohort. J Ren Nutr. 2016;26:72–80.
- Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–398.
- Hirai K, Ookawara S, Morishita Y. Sarcopenia and physical inactivity in patients with chronic kidney disease. Nephrourol Mon. 2016;8:e37443.
- Herbelin A, Ureña P, Nguyen AT, et al. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int. 1991;39:954–960.
- Qureshi AR, Alvestrand A, Divino-Filho JC, et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol. 2002;13 Suppl 1:S28–S36.
- Marcelli D, Usvyat LA, Kotanko P, et al. Body composition and survival in dialysis patients: results from an international cohort study. Clin J Am Soc Nephrol. 2015;10:1192–1200.
- Rosenberger J, Kissova V, Majernikova M, et al. Body composition monitor assessing malnutrition in the hemodialysis population independently predicts mortality. J Ren Nutr. 2014;24:172–176.
- Broers NJ, Martens RJ, Cornelis T, et al. Body composition in dialysis patients: a functional assessment of bioimpedance using different prediction models. J Ren Nutr. 2015;25:121–128.
- Ren H, Gong D, Jia F, et al. Sarcopenia in patients undergoing maintenance hemodialysis: incidence rate, risk factors and its effect on survival risk. Ren Fail. 2016;38:364–371.
- Su CT, Yabes J, Pike F, et al. Changes in anthropometry and mortality in maintenance hemodialysis patients in the HEMO Study. Am J Kidney Dis. 2013;62:1141–1150.
- Konings CJ, Kooman JP, Schonck M, et al. Influence of fluid status on techniques used to assess body composition in peritoneal dialysis patients. Perit Dial Int. 2003;23:184–190.
- Kim JC, Kalantar-Zadeh K, Kopple JD. Frailty and protein-energy wasting in elderly patients with end stage kidney disease. J Am Soc Nephrol. 2013;24:337–351.
- Kim JK, Kim SG, Oh JE, et al. Impact of sarcopenia on long-term mortality and cardiovascular events in patients undergoing hemodialysis. Korean J Intern Med. 2017;23. DOI:10.3904/kjim.2017.083
- Kim SK, Kwon YH, Cho JH, et al. Changes in body composition according to age and sex among young non-dia0betic Korean adults: the Kangbuk Samsung health study. Endocrinol Metab (Seoul). 2017;32:442–450.
- Wang YW, Lin TY, Peng CH, et al. Factors associated with decreased lean tissue index in patients with chronic kidney disease. Nutrients. 2017;9. DOI:10.3390/nu9050434
- Biasioli S, Foroni R, Petrosino L. Effect of aging on the body composition of dialyzed subjects. Comparison with normal subjects. Asaio J. 1993;39:M596–M601.
- Dai L, Golembiewska E, Lindholm B, et al. End-stage renal disease, inflammation and cardiovascular outcomes. Contrib Nephrol. 2017;191:32–43.
- Lee BT, Ahmed FA, Hamm LL, et al. Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease. BMC Nephrol. 2015;16:77.
- Barreto DV, Barreto FC, Liabeuf S, et al. Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int. 2010;77:550–556.
- Ammirati E, Cannistraci CV, Cristell NA, et al. Identification and predictive value of interleukin-6+ interleukin-10+ and interleukin-6- interleukin-10+ cytokine patterns in ST-elevation acute myocardial infarction. Circ Res. 2012;26(111):1336–1348.
- Kaizu Y, Ohkawa S, Odamaki M, et al. Association between inflammatory mediators and muscle mass in long-term hemodialysis patients. Am J Kidney Dis. 2003;42:295–302.
- Atkins JL, Whincup PH, Morris RW, et al. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc. 2014;62:253–260.
- Tian S, Xu Y. Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies. Geriatr Gerontol Int. 2016;16:155–166.